AR 177

Drug Profile

AR 177

Alternative Names: T 30177; Zintevir

Latest Information Update: 09 Jul 2001

Price : $50

At a glance

  • Originator Antigenics
  • Class Oligonucleotides
  • Mechanism of Action HIV integrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 09 Jul 2001 Aronex is seeking a partner to fund further development of AR 177 (
  • 11 Jan 2000 Discontinued-II for HIV infections treatment in USA (IV)
  • 13 May 1999 A precllinical study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top